| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10052869 | HBV | ENSG00000159110.22 | protein_coding | IFNAR2 | No | No | 3455 | P48551 Q9BUA0 |
| TVIS30015953 | HIV | ENSG00000159110.22 | protein_coding | IFNAR2 | No | No | 3455 | P48551 Q9BUA0 |
| TVIS30010733 | HIV | ENSG00000159110.22 | protein_coding | IFNAR2 | No | No | 3455 | P48551 Q9BUA0 |
| TVIS30008061 | HIV | ENSG00000159110.22 | protein_coding | IFNAR2 | No | No | 3455 | P48551 Q9BUA0 |
| TVIS30008062 | HIV | ENSG00000159110.22 | protein_coding | IFNAR2 | No | No | 3455 | P48551 Q9BUA0 |
| TVIS30074702 | HIV | ENSG00000159110.22 | protein_coding | IFNAR2 | No | No | 3455 | P48551 Q9BUA0 |
| TVIS30054550 | HIV | ENSG00000159110.22 | protein_coding | IFNAR2 | No | No | 3455 | P48551 Q9BUA0 |
| TVIS30054551 | HIV | ENSG00000159110.22 | protein_coding | IFNAR2 | No | No | 3455 | P48551 Q9BUA0 |
| TVIS30054552 | HIV | ENSG00000159110.22 | protein_coding | IFNAR2 | No | No | 3455 | P48551 Q9BUA0 |
| TVIS44011233 | HTLV-1 | ENSG00000159110.22 | protein_coding | IFNAR2 | No | No | 3455 | P48551 Q9BUA0 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | IFNAR2 |
|---|---|
| DrugBank ID | DB00018 |
| Drug Name | Interferon alfa-n3 |
| Target ID | BE0000385 |
| UniProt ID | P48551 |
| Regulation Type | agonist |
| PubMed IDs | 17139284; 17016423; 15898717; 19955815; 16953837; 11752352 |
| Citations | Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Dhalluin C, Ross A, Huber W, Gerber P, Brugger D, Gsell B, Senn H: Structural, kinetic, and thermodynamic analysis of the binding of the 40 kDa PEG-interferon-alpha2a and its individual positional isomers to the extracellular domain of the receptor IFNAR2. Bioconjug Chem. 2005 May-Jun;16(3):518-27.@@Ishii K, Shinohara M, Sawa M, Kogame M, Higami K, Sano M, Morita T, Sumino Y: Interferon alpha receptor 2 expression by peripheral blood monocytes in patients with a high viral load of hepatitis C virus genotype 1 showing substitution of amino Acid 70 in the core region. Intervirology. 2010;53(2):105-10. doi: 10.1159/000264200. Epub 2009 Dec 3.@@Yano H, Ogasawara S, Momosaki S, Akiba J, Kojiro S, Fukahori S, Ishizaki H, Kuratomi K, Basaki Y, Oie S, Kuwano M, Kojiro M: Growth inhibitory effects of pegylated IFN alpha-2b on human liver cancer cells in vitro and in vivo. Liver Int. 2006 Oct;26(8):964-75.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. |
| Groups | Approved; Investigational |
| Direct Classification | Peptides |
| SMILES | |
| Pathways | |
| PharmGKB | PA164746228 |
| ChEMBL | CHEMBL2109047 |
